Optimization of therapy for miscarriage in patients with acquired thrombophilia (Literature Review)

Main Article Content

Sodiqova D.R
Yunusalieva D.A

Abstract

Thrombophilias are still one of the pressing problems in obstetric practice.The last decade of the 20th century was marked by the discovery of a large number of genetically determined and acquired thrombophilias, which repeatedly increase the risk of thrombosis and thromboembolism during pregnancy.Currently, there is no doubt that thrombosis is one of the main causes of fatal outcomes in the world. Many researchers indicate that for every 1000 births there are 2-5 cases of thrombotic complications [1, 2]. Up to 50% of venous thromboses occur in patients under 40 years of age and are usually associated with pregnancy. Some authors note that the risk of venous thromboembolic complications in pregnant women is 4-10 times higher than in non-pregnant women of the same age. The risk increases with the onset of pregnancy and becomes maximum in the postpartum period [16, 17].This may be due to the fact that all the classical components of Virchow's triad are present even in uncomplicated pregnancy and labor. Blood flow velocity in the vessels of the lower extremities decreases by almost 50%, changes in the hemostasis system occur (which are primarily manifested in the tendency

Article Details

How to Cite
Sodiqova D.R, & Yunusalieva D.A. (2024). Optimization of therapy for miscarriage in patients with acquired thrombophilia (Literature Review). The Peerian Journal, 34, 1–8. Retrieved from https://peerianjournal.com/index.php/tpj/article/view/927
Section
Articles

References

Kujovich J.L.. Thrombophilia and pregnancy complications / Kujovich J.L.. // Am. J. Obstet.

Cynecol. - 2004. - Vol. 191. - P. 412-424.

Eldor A. Thrombophiliya, thrombosis and pregnancy / Eldor A. // Thromb. Haemost. - 2001.

- Vol. 86. - P. 1045-1111.

Cris J.C. Lov molecular - Weight heparin vercus low-close aspirin in women with one fetal

loss and a constitutional thrombophilic disorder / Cris J.C., Mercier E., Quere L. et al. //

Blood. - 2004. - Vol. 103. - P. 3695-3699.

Fanguharson R.G. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial

of treatment / Fanguharson R.G., Qucnby S., Creaves M. // Obstet. and Gynecol. - 2002. -

Vol. 100. - P. 408- 413.

Dizon-Towson D. The relationship of the factor V Leiden mutation and fetus / Dizon-Towson

D., Miller C., Sibai B. et al. // Obsted. and Gynecol. - 2005. - Vol. 106. - P. 517-524.

Lin J., August P. Genetic thrombophilias and preeclampsia. A meta-analysis / Lin J., August.

// Obstet. and Gynecol. - 2005. - Vol. 105. - P. 182-192.

Putilova N.V. Thrombophilia and pregnancy, prediction of neonatal complications and

optimization of management tactics / Putilova N.V. // Obstetrics and Gynecology. - 2011. -

№ 4. - С. 31-35.

Cumming A.M. Development of resistance to activated protein C during pregnancy /

Cumming A.M. et al. // Am. J. Haematal. - 1995. - Vol. 90. - P. 725-727.

Ailamazyan E.K. Hereditary thrombophilia: a differentiated approach to assessing the risk of

obstetric complications / Ailamazyan E.K., Zainulina M.S. // Obstetrics and Gynecology. -

- № 3. - С. 3-9.

Clark P. The GOAL. Study: a prospective examination of the impact of factor V Leiden and

ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes / Clark P. et al.

// Br. J. Haematol. - 2008. - Vol. 140, №2. - P. 236-240.

Preston F.E.. Increased fetal loss in Women with heritable thrombophilia / Preston F.E. et al.

// Lancet. - 1996. - Vol. 348, № 9032. - Р. 913-916.

Rey E. Thrombophilic disorders and fetal loss: a metaanalysis / Rey E. et al. // Lancet. - 2003.

- Vol. 361, № 9361. - Р. 901-908.13. Murphy R.P. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile

methylenetetrahydrofolate reductase polymorphisms in pregnancy / Murphy R.P. et al

//Arteriaseler. Thromb. Vasc. Biol. - 2000. - Vol. 20, № 1. - Р. 266-270.

Greer I.A. Low mole weight heparin for pregnancy complications? / Greer I.A. // Thromb.

Res. - 2009. - Vol. 123. - Suppl. 3. - P. 22-25.

Rai R. Factor V Leiden and acquired activated protein C resistance among 1000 women with

recurrent miscarriage / Rai R. et al. // Hum. Reprod. - 2001. - Vol. 16, № 5. - Р. 961-965.

Simioni P. Thrombophilia and gestational VTE. Thrombophilia and gestational VTE /

Simioni P. // Thrombosis Research. - 2009, 123: Suppl. 2: 41-44.

James A.H.. Thrombosis during pregnancy and the postpartum period / James A.H., Tapson

V.F., Coldhaber S.Z.. // Am J. Obstet. Gynec. - 2005. - № 193. - Р. 216-219.

Shabanova NA Modern methods of medical and surgical prevention of venous

thromboembolic complications in pregnancy and the postpartum period / Shabanova NA,

Zainulina MS, Gordeev NA, Makogonova ME // Russian Herald of Obstetrics and

Gynecology. - 2010. - Т. 10, № 5. - С. 54-59.

Chulkov V.S. Clinical course of pregnancy, hemostasis and endothelial function in patients

with arterial hypertension and risk factors for thrombogenic complications / Chulkov V.S.,

Sinitsyn S.P., Vereina N.K. // Russian Herald of Obstetrics and Gynecology. - 2010. - Т. 10,

№ 3. - С. 9-12.

Lingvist P.G. Postpartum thromboembolism: severe events might be preventable using a new

risk score model / Lingvist P.G., Torsson J., Almgwist A. et al // Vasc. Health Risk Manag. -

- Vol. 4, №5. - P. 1081-1087.